How big is the U.S. home infusion therapy market?

The U.S. home infusion therapy market size was estimated at USD 20.42 billion in 2024 and is expected to reach USD 21.95 billion in 2025.

What is the U.S. home infusion therapy market growth?

The U.S. home infusion therapy market is expected to grow at a compound annual growth rate of 7.78% from 2025 to 2033 to reach USD 39.96 billion by 2033.

Which segment accounted for the largest U.S. home infusion therapy market share?

Anti-Infective segment dominated the U.S. home infusion therapy market with a share of 26.94% in 2024. This is attributable to extensive use as antifungal, antibiotics, and antiviral agent at-home care.

Who are the key players in U.S. home infusion therapy market?

Some key players operating in the U.S. home infusion therapy market include B. Braun Melsungen; Baxter International; Caesarea Medical Electronics Ltd.; CareFusion; Fresenius Kabi; ICU Medical; JMS CO., LTD.; Smiths Medical, Inc.; Terumo Corporation

What are the factors driving the U.S. home infusion therapy market?

Key factors that are driving the market growth include rise in elderly population prone to various severe disorders and increasing preference for home therapy.